Regulatory11 min read

Site Licence for Natural Health Products in Canada: Everything You Need to Know

Nostrum Health Regulatory Team·

What Is a Site Licence?

A Site Licence is Health Canada's authorization for any facility that manufactures, packages, labels, or imports natural health products (NHPs) in Canada. It's issued under the Natural Health Products Regulations (NHPR) and certifies that the site meets Good Manufacturing Practices (GMP) for NHPs.

Think of it this way: the NPN is the product licence (what you're selling). The Site Licence is the facility licence (where it's made, stored, or imported through).

Who Needs a Site Licence?

You need one if you:

  • Manufacture NHPs in Canada (compounding, encapsulating, tableting)
  • Package NHPs (bottling, blister packing, sachet filling)
  • Label NHPs (applying any label to a finished product)
  • Import NHPs into Canada for sale
  • Distribute NHPs from a Canadian facility

You do NOT need one if you only:

  • Retail NHPs (sell them as-is to consumers)
  • Broker NHPs (facilitate transactions without touching product)

The Foreign Manufacturer Problem

If you're a US or international manufacturer, you cannot import NHPs directly into Canada without a Canadian Site Licence holder. Your options are:

  1. Set up a Canadian subsidiary and obtain your own Site Licence
  2. Use a Canadian distributor/importer who already holds one

Option 2 is what most manufacturers choose — and it's exactly what Nostrum Health provides.

Site Licence Requirements

Good Manufacturing Practices (GMP)

Health Canada's GMP requirements for NHPs include:

  • Sanitation — Written sanitation program, pest control, clean facilities
  • Equipment — Properly maintained, calibrated, and validated equipment
  • Personnel — Trained staff with defined roles and responsibilities
  • Quality Assurance — A QAP who reviews and releases every batch
  • Documentation — Written SOPs for every process, batch records, deviation reports
  • Complaint handling — Documented process for receiving, investigating, and resolving complaints
  • Recall procedures — Written recall protocol in case of safety issues

Quality Assurance Person (QAP)

Every Site Licence holder must designate a QAP — someone who:

  • Reviews and approves each batch before release to market
  • Has appropriate education and experience (science degree + training in GMP)
  • Can halt distribution of any batch that doesn't meet specifications
  • Maintains oversight of all quality-related activities

The QAP is a legal requirement. No QAP = no Site Licence.

How Long Does It Take?

ActivityTypical Timeline
Prepare GMP documentation2–4 weeks
Submit Site Licence application1 day
Health Canada review30–90 days
Address deficiencies (if any)2–6 weeks

Total: 2–6 months from start to licence, assuming no major deficiencies.

Site Licence Application Fees

ItemCost
Health Canada application fee$250 (Class 1 site)
GMP documentation development$5,000–$20,000 (if hiring a consultant)
QAP training and qualification$2,000–$5,000
Facility upgrades (if needed)Varies widely

Some brands work with a Canadian Site Licence holder rather than building every regulated activity in-house. The correct arrangement depends on the activities, sites, products, quality system, and written responsibilities involved.

Operating Under an Existing Site Licence

A brand may coordinate regulated Canadian activities through appropriately licensed sites and qualified parties. That does not remove the brand's obligation to use compliant products, records, labels, claims, and supply-chain arrangements.

Nostrum Health can assess a proposed Canadian operating model and define which responsibilities can be supported within an agreed scope. Depending on the product and arrangement, that work may include:

  • Site Licence and foreign-site pathway assessment
  • Quality documentation and QAP release coordination
  • Canadian import, storage, and record-keeping planning
  • Bilingual label and NPN readiness review
  • Commercial launch planning after regulatory dependencies are satisfied

How Nostrum Health Can Help

We connect regulatory assessment with quality, import, operational, and commercial planning. Scope and commercial terms are confirmed only after reviewing the products, manufacturing sites, documentation, and intended Canadian activities.

Discuss your Canadian market-entry plan →

Key Takeaways

  • A Site Licence is required for any facility that manufactures, packages, labels, or imports NHPs in Canada
  • Foreign manufacturers must use a Canadian Site Licence holder to import
  • Getting your own Site Licence takes 2–6 months and costs thousands in documentation and facility upgrades
  • A compliant model can involve appropriately licensed Canadian and foreign sites with clearly assigned responsibilities
  • Product licensing, site licensing, quality release, importation, and commercial launch should be assessed together

Planning a Canadian launch? Discuss the regulatory and operating model with Nostrum Health.

Ready to sell in Canada?

Discuss a scoped regulatory engagement, or apply for the Manufacturer-to-Amazon Partnership. Partnership applicants provide 500 saleable units DDP and agreed deductions apply to launch proceeds.

Apply Now